top of page

VAXNEUVANCE® Suspension for Injection

Product details

Registration number: SIN16944P

Classification: Prescription Only

Active ingredients:

  • (MBC) Pneumococcal Polysaccharide Serotype 1 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 14 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 18C conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 19A conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 19F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 22F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 23F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 3 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 33F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 4 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 5 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 6A conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 6B conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 7F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 9V conjugated to CRM197

Strength:

  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 4μg
  • 2μg
  • 2μg

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.

ATC code: J07AL02

HSA approval date: 7 February 2024

Manufacturer(s): MSD International GmbH T/A MSD Ireland (Carlow)

Manufacturing country/countries: IRELAND

What are the HSA registration number and classification for VAXNEUVANCE® Suspension for Injection?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16944P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for VAXNEUVANCE® Suspension for Injection?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • (MBC) Pneumococcal Polysaccharide Serotype 1 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 14 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 18C conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 19A conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 19F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 22F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 23F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 3 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 33F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 4 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 5 conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 6A conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 6B conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 7F conjugated to CRM197
  • (MBC) Pneumococcal Polysaccharide Serotype 9V conjugated to CRM197

Strength:

  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 2μg
  • 4μg
  • 2μg
  • 2μg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for VAXNEUVANCE® Suspension for Injection?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for VAXNEUVANCE® Suspension for Injection?

According to the HSA dataset updated 7 August 2026:

Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for VAXNEUVANCE® Suspension for Injection?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): MSD International GmbH T/A MSD Ireland (Carlow)

Manufacturing country/countries: IRELAND

Source for this answer

Where can I look up VAXNEUVANCE® Suspension for Injection in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16944P or the exact product name VAXNEUVANCE® Suspension for Injection. The general register link does not preselect this product.

Source for this answer

What are the source dates for this VAXNEUVANCE® Suspension for Injection record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this VAXNEUVANCE® Suspension for Injection record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16944P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page